GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » Debt-to-Revenue

Gujarat Terce Laboratories (BOM:524314) Debt-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Gujarat Terce Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.0 Mil. Gujarat Terce Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.0 Mil. Gujarat Terce Laboratories's annualized Revenue for the quarter that ended in Dec. 2023 was ₹520.8 Mil. Gujarat Terce Laboratories's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.


Gujarat Terce Laboratories Debt-to-Revenue Historical Data

The historical data trend for Gujarat Terce Laboratories's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Terce Laboratories Debt-to-Revenue Chart

Gujarat Terce Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.07 0.19 0.17 0.16

Gujarat Terce Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.14 - 0.09 -

Competitive Comparison of Gujarat Terce Laboratories's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Terce Laboratories's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Terce Laboratories's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Terce Laboratories's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Gujarat Terce Laboratories's Debt-to-Revenue falls into.



Gujarat Terce Laboratories Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Gujarat Terce Laboratories's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(58.11 + 14.612) / 467.825
=0.16

Gujarat Terce Laboratories's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 520.808
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Gujarat Terce Laboratories Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gujarat Terce Laboratories's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Terce Laboratories (BOM:524314) Business Description

Traded in Other Exchanges
N/A
Address
Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines